Very light in detail
Sydney, Australia, 2 May 2022: Imugene (ASX: IMU) today announced termination of its
supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., USA.
Imugene is continuing with its clinical trial to evaluate the safety and efficacy with the use of
Imugene’s HER-Vaxx, a B-cell activating immunotherapy in patients with HER-2 positive
gastric cancer in combination with anti-PD-1 therapy.
Very light in detailSydney, Australia, 2 May 2022: Imugene (ASX:...
-
- There are more pages in this discussion • 445 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $400.2K | 8.603M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1876197 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 613421 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |